medroxyprogesterone acetate has been researched along with Genital Herpes in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (14.29) | 18.2507 |
2000's | 3 (21.43) | 29.6817 |
2010's | 8 (57.14) | 24.3611 |
2020's | 1 (7.14) | 2.80 |
Authors | Studies |
---|---|
Aceves, KM; Cherpes, TL; Gabriel, JM; Hatfield, AM; Kaur, B; Kwiek, JJ; Quispe Calla, NE; Torres, AR; Trout, W; Vicetti Miguel, RD | 1 |
Gollub, EL; Jones, HE; McCarthy, KJ; Ralph, L; van de Wijgert, J | 1 |
Aceves, KM; Cherpes, TL; Quispe Calla, NE; Torres, A; Vicetti Miguel, RD | 1 |
Herold, BC; Irvin, SC; Murphy, K | 1 |
Aravantinou, M; Blanchard, J; Derby, N; Frank, I; Gettie, A; Grasperge, B; Kenney, J; Kleinbeck, K; Lifson, JD; Piatak, M; Robbiani, M; Zydowsky, TM | 1 |
Baeten, JM; Heffron, R | 1 |
Grabowski, MK; Gray, RH; Kagaayi, J; Kigozi, G; Lutalo, T; Makumbi, F; Nalugoda, F; Quinn, TC; Redd, AD; Reynolds, SJ; Serwadda, D; Tobian, AAR; Wawer, MJ | 1 |
Boyaka, PN; Cherpes, TL; Hall-Stoodley, L; Kaur, B; Pavelko, SD; Quispe Calla, NE; Trout, W; Vicetti Miguel, RD | 1 |
Duff, P; Montaner, JSG; Nguyen, P; Ogilvie, G; Shannon, K; Shoveller, J; SocĂas, ME | 1 |
Carr, DJ; Thapa, M | 1 |
Ashkar, AA; Kaushic, C; Reid, LA; Rosenthal, KL | 1 |
McClelland, RS | 1 |
Bozzola, JJ; Drew, MD; Kepple, L; McDermott, MR; Parr, EL; Parr, MB | 1 |
Barratt, RA; Cone, RA; Hoen, TE; Whaley, KJ; Zeitlin, L | 1 |
3 review(s) available for medroxyprogesterone acetate and Genital Herpes
Article | Year |
---|---|
Hormonal Contraceptives and the Acquisition of Sexually Transmitted Infections: An Updated Systematic Review.
Topics: Contraceptives, Oral, Hormonal; Female; Herpes Genitalis; Humans; Medroxyprogesterone Acetate; Prospective Studies; Risk; Risk Assessment; Sexually Transmitted Diseases; Trichomonas Infections | 2019 |
Research gaps in defining the biological link between HIV risk and hormonal contraception.
Topics: Animals; Contraception; Contraceptive Agents, Female; Female; Herpes Genitalis; HIV Infections; Humans; Immunity, Mucosal; Intercellular Junctions; Medroxyprogesterone Acetate; Microbiota; Mucous Membrane; Permeability; Risk; Vagina | 2014 |
Effect of exogenous hormones.
Topics: Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Drug Implants; Female; Genitalia, Female; Herpes Genitalis; Herpesvirus 2, Human; HIV Infections; HIV-1; Humans; Medroxyprogesterone Acetate; Prospective Studies | 2005 |
11 other study(ies) available for medroxyprogesterone acetate and Genital Herpes
Article | Year |
---|---|
Norethisterone Enanthate Increases Mouse Susceptibility to Genital Infection with Herpes Simplex Virus Type 2 and HIV Type 1.
Topics: Animals; Contraceptive Agents, Female; Desmoglein 1; Disease Susceptibility; Female; Herpes Genitalis; Herpesvirus 2, Human; HIV Infections; HIV-1; Medroxyprogesterone Acetate; Mice; Mice, Inbred C57BL; Mice, SCID; Mucous Membrane; Norethindrone; Permeability; Vagina | 2020 |
Depot-medroxyprogesterone acetate reduces genital cell-cell adhesion molecule expression and increases genital herpes simplex virus type 2 infection susceptibility in a dose-dependent fashion.
Topics: Animals; Cell Adhesion Molecules; Contraceptive Agents, Female; Desmocollins; Desmoglein 1; Disease Susceptibility; Female; Gene Expression; Herpes Genitalis; Herpesvirus 2, Human; Medroxyprogesterone Acetate; Mice; Mice, Inbred C57BL; Mucous Membrane; Vagina | 2019 |
Short communication: a repeated simian human immunodeficiency virus reverse transcriptase/herpes simplex virus type 2 cochallenge macaque model for the evaluation of microbicides.
Topics: Animals; Anti-Infective Agents; Coinfection; Contraceptive Agents, Female; Disease Models, Animal; Female; Herpes Genitalis; Herpesvirus 2, Human; HIV Reverse Transcriptase; Macaca mulatta; Medroxyprogesterone Acetate; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Treatment Outcome; Vagina; Vaginal Creams, Foams, and Jellies; Virus Shedding | 2014 |
Contraception and sexually transmitted infections: risks and benefits, hypotheses and evidence.
Topics: Contraceptive Agents, Female; Female; Herpes Genitalis; Herpesvirus 2, Human; Humans; Male; Medroxyprogesterone Acetate; Pregnancy | 2015 |
Use of injectable hormonal contraception and women's risk of herpes simplex virus type 2 acquisition: a prospective study of couples in Rakai, Uganda.
Topics: Adult; Contraceptive Agents, Female; Female; Herpes Genitalis; Herpesvirus 2, Human; Humans; Incidence; Injections; Male; Medroxyprogesterone Acetate; Pregnancy; Proportional Hazards Models; Prospective Studies; Risk Factors; Seroconversion; Sexual Partners; Uganda; Young Adult | 2015 |
Medroxyprogesterone acetate and levonorgestrel increase genital mucosal permeability and enhance susceptibility to genital herpes simplex virus type 2 infection.
Topics: Animals; Contraceptive Agents, Female; Disease Models, Animal; Disease Susceptibility; Estrogens; Female; Herpes Genitalis; Herpesvirus 2, Human; Levonorgestrel; Medroxyprogesterone Acetate; Mice; Mucous Membrane; Permeability; Vagina | 2016 |
Use of injectable hormonal contraception and HSV-2 acquisition in a cohort of female sex workers in Vancouver, Canada.
Topics: Adult; British Columbia; Cohort Studies; Contraception Behavior; Contraceptive Agents, Female; Female; Herpes Genitalis; Humans; Incidence; Injections; Medroxyprogesterone Acetate; Prospective Studies; Sex Workers; Young Adult | 2017 |
Herpes simplex virus type 2-induced mortality following genital infection is blocked by anti-tumor necrosis factor alpha antibody in CXCL10-deficient mice.
Topics: Animals; Antibodies; Antineoplastic Agents, Hormonal; Brain Stem; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Chemokine CXCL10; Chemokine CXCL9; Female; Herpes Genitalis; Herpesvirus 2, Human; Medroxyprogesterone Acetate; Mice; Mice, Knockout; Spinal Cord; Tumor Necrosis Factor-alpha; Vagina | 2008 |
Progesterone increases susceptibility and decreases immune responses to genital herpes infection.
Topics: Animals; Antibodies, Viral; Disease Susceptibility; Female; Herpes Genitalis; Herpesvirus 2, Human; Herpesvirus Vaccines; Immunity; Medroxyprogesterone Acetate; Mice; Mice, Inbred C57BL; Progesterone; Reproduction; Vaccines, Attenuated; Vagina; Vaginal Diseases; Viral Envelope Proteins | 2003 |
A mouse model for studies of mucosal immunity to vaginal infection by herpes simplex virus type 2.
Topics: Animals; B-Lymphocytes; Disease Models, Animal; Estradiol; Estrus; Female; Herpes Genitalis; Herpesvirus 2, Human; Immunity; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Mucous Membrane; Plasma Cells; Pregnancy; Pregnancy Complications, Infectious; T-Lymphocytes; Vagina | 1994 |
Nonoxynol-9 protects mice against vaginal transmission of genital herpes infections.
Topics: Animals; Female; Herpes Genitalis; Humans; Medroxyprogesterone Acetate; Mice; Mice, Inbred C57BL; Nonoxynol; Pregnancy; Pregnancy Complications, Infectious; Sexually Transmitted Diseases; Simplexvirus; Vagina | 1993 |